Aptamers: A Feasible Technology in Cancer Immunotherapy
Aptamers are single-chained RNA or DNA oligonucleotides (ODNs) with three-dimensional folding structures which allow them to bind to their targets with high specificity. Aptamers normally show affinities comparable to or higher than that of antibodies. They are chemically synthesized and therefore l...
Main Authors: | M. M. Soldevilla, H. Villanueva, F. Pastor |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/1083738 |
Similar Items
-
Aptamers: A New Technological Platform in Cancer Immunotherapy
by: Fernando Pastor
Published: (2016-10-01) -
Aptamer-iRNAs as Therapeutics for Cancer Treatment
by: Mario M. Soldevilla, et al.
Published: (2018-10-01) -
In Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study'TIM3 Aptamers Binding
by: Obdulia Rabal, et al.
Published: (2016-01-01) -
CD28 Aptamers as Powerful Immune Response Modulators
by: Fernando Pastor, et al.
Published: (2013-01-01) -
Aptamers and cancer
by: Nasrin Yazdanpanahi, et al.
Published: (2016-04-01)